August 6, 2021

Prior research has revealed significant racial disparities in the diagnosis of lung cancer. Researchers from the University of Colorado examined differences in initial diagnostic imaging use and compared how these data relate to cancer-specific survival rates in Hispanic, non-Hispanic white, and non-Hispanic Black patients diagnosed with non-small cell lung cancer. The researchers collected data from...

In the United States, thousands of patients are treated for non-small cell lung cancer (NSCLC) each year. For localized NSCLC, there is a 63% 5-year survival rate. There is a 35% 5-year survival rate for regional NSCLC. With the improvements made in lung cancer treatment, including new targeted treatments and immunotherapies, patients with NSCLC are...

Evidence has shown that patients with lung cancer who do not receive guideline-concordant treatment experience worse outcomes. It is crucial that all patients are provided with treatment that meets appropriate clinical guidelines. Researchers from the University of Michigan examined the level of adherence to minimal lung cancer treatment guidelines recommended by the National Comprehensive Cancer Network...

Lung cancer has the highest mortality rate of all cancers. To improve patient survival rates, it is imperative that lung cancer is diagnosed early and that the most effective treatments are available and performed in a timely manner for all populations. Previous research has identified racial and sex-related disparities in the treatment of patients with...